Crohn's Disease and Colitis Trial, Recruiting (NCT06938295)

Crohn's Disease and Colitis Trial, Recruiting NCT06938295 Sponsor: Asian Institute of Gastroenterology, India Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT06938295 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 75 years old.
You have been diagnosed with inflammatory bowel disease (IBD), a condition causing inflammation in the digestive tract, specifically affecting the lower small intestine and/or large intestine.
Your condition is currently stable at the time of your assessment.
You are willing and able to have two types of bowel ultrasound scans (using different types of equipment) as well as a camera examination of the bowel (colonoscopy).
You are willing to give your written agreement (informed consent) to take part in the study.

Who may not be able to join:

You are currently pregnant or breastfeeding.
You have a health condition or known intolerance that means it would not be safe for you to have a colonoscopy (a camera examination of the bowel).
You are not able to give your own agreement (informed consent) to take part.
You have a condition that could make ultrasound scans difficult to perform clearly, such as severe obesity or difficulty cooperating with the procedure.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +91-8945906823

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06938295

Sponsor: Asian Institute of Gastroenterology, India

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: +91-8945906823

More information: https://clinicaltrials.gov/study/NCT06938295

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 75 years old.
You have been diagnosed with inflammatory bowel disease (IBD), a condition causing inflammation in the digestive tract, specifically affecting the lower small intestine and/or large intestine.
Your condition is currently stable at the time of your assessment.
You are willing and able to have two types of bowel ultrasound scans (using different types of equipment) as well as a camera examination of the bowel (colonoscopy).
You are willing to give your written agreement (informed consent) to take part in the study.

Who may not be able to join:

You are currently pregnant or breastfeeding.
You have a health condition or known intolerance that means it would not be safe for you to have a colonoscopy (a camera examination of the bowel).
You are not able to give your own agreement (informed consent) to take part.
You have a condition that could make ultrasound scans difficult to perform clearly, such as severe obesity or difficulty cooperating with the procedure.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Asian Institute of Gastroenterology, India

Registry

ClinicalTrials.gov

Start date

14 September 2024

Est. completion

30 October 2025

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Diagnostic Accuracy of Mid-End and High-End Ultrasound in Detecting Ileocolonic Inflammation Compared to Ileo-Colonoscopy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov